Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Vaxxas (Australia)
h-index: 16
Total citations: 896
Total papers: 38
Homepage:
http://www.vaxxas.com/
Recent papers from Vaxxas (Australia)
Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults
Vaccines · 2025
Tracking antigen presenting cells to uncover the intrinsic immunostimulatory properties of microarray vaccine patches using a fluosphere-based assay
Vaccine X · 2025
Benefits and challenges of high-density microarray patches for vaccination among older adults: A qualitative study
Health Policy and Technology · 2025
Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses
Heliyon · 2025
Vaccine microarray patch self-administration: A preliminary study in adults 50 years of age and over
Vaccine · 2025
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin
Journal of Controlled Release · 2024
Herpes simplex virus spreads rapidly in human foreskin, partly driven by chemokine-induced redistribution of Nectin-1 on keratinocytes
PLoS Pathogens · 2024
Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein
Journal of General Virology · 2024
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial
Vaccines · 2023
Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine
Molecular Therapy — Nucleic Acids · 2023
Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis
SHILAP Revista de lepidopterología · 2023
Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates
Vaccine · 2023
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product
Journal of Controlled Release · 2023
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial
2023
Evaluation of the self-administration potential of high-density microarray patches to human skin: A preliminary study
Human Vaccines & Immunotherapeutics · 2023
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Molecular Psychiatry · 2022
An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses
Advanced NanoBiomed Research · 2022
Local Response and Barrier Recovery in Elderly Skin Following the Application of High-Density Microarray Patches
Vaccines · 2022
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern
Vaccines · 2022
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective
Human Vaccines & Immunotherapeutics · 2022